Pulsesight Therapeutics
PulseSight is an ophthalmology drug development company developing disruptive non-viral gene therapies with minimally-invasive delivery technology to treat major eye diseases. Our mission is to develop life-changing solutions for patients with diseases leading to sight loss.
7-day free trial · no credit card
Verified contacts
8
available on Kipplo
LinkedIn employees
10
11 to 50 range
Open roles
—
no listings
Distinct roles
7
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 8 verified contacts at Pulsesight Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
8 contacts with verified email or phone · masked until revealed.
- GP
Gina Pinto
Directrice Administrative Et Financière · Finance & Accounting
EmailPhone - KB
Karine Bigot
Head of Pharmacology and Toxicology · Research & Development
EmailPhone - JG
Judith Greciet
Chief Executive Officer · General Business & Management
EmailPhone - RB
Romain Benard
Senior Project Manager, Medical Device and Pharmacology · Other
EmailPhone - TB
Thierry Bordet
É () · Other
EmailPhone
Showing 5 of 8 verified contacts
Top roles at Pulsesight Therapeutics
7 distinct titles indexed · top 7 shown.
- 2senior preclinical project leader - in charge of bioanalytical methods
- 1- ä
- 1chief executive officer
- 1directrice administrative et financière
- 1head of pharmacology and toxicology
- 1senior project manager, medical device and pharmacology
- 1é ()
Sign up to unlock all 8 contacts at Pulsesight Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 8 verified contacts at Pulsesight Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.